Professional Documents
Culture Documents
02107020/CAPE/KMS 2021
C A R I B B E A N E X A M I N A T I O N S C O U N C I L
BIOLOGY
UNIT 1 - Paper 02
MAY/JUNE 2021
- 2 -
02107020/CAPE/KMS 2021
BIOLOGY
UNIT 1 – PAPER 02
KEY AND MARK SCHEME
Question 1
(a)
Diagram
N.B.- Candidates are not expected to draw in the several less dense
areas within the cytoplasm in their diagram
1 mark XS
- 3 -
02107020/CAPE/KMS 2021
BIOLOGY
UNIT 1 – PAPER 02
KEY AND MARK SCHEME
Annotations
Question 1 cont’d
For cell sap, accept either cell sap OR any two components
Any two
Identification of 2 structure =2mks, function of each structure= 2x
1mk =2mks [4 marks KC]
Question 1 cont’d
Sample Responses
Total 30 marks
- 2 -
02107020/CAPE/KMS 2021
BIOLOGY
UNIT 1 – PAPER 02
KEY AND MARK SCHEME
Question 2
(a) (i)
S - phosphate
T - deoxyribose
U - cytosine
V - thymine
1 mark for label lines not crossing (at least two drawn)
1 mark for no arrowheads on all line
IF NO LABEL LINES:
3-4 correct labels – 2 marks
1-2 correct labels - 1 mark
[5 marks XS]
Question 2 cont’d
Any 1, 1 mark KC
(iv) Roles of messenger RNA (mRNA) and transfer RNA (tRNA) in the
production of polypeptides
mRNA
1. Provides instructions/information copied from the DNA (base
sequence)/transcription /gene/ genetic code for the formation
of a chain of amino acids in a polypeptide/protein (protein
synthesis)
4 marks KC
Question 2 cont’d
(b) (i) Change in the gene which results in the production of abnormal
haemoglobin
• one base is changed/substituted in the sequence of DNA(coding
for normal Hb) / Adenine /A replaces thymine/T/ CTT is changed
to CAT /single base substitution
1 mark
(ii) How low oxygen saturation results in a change of the shape of red
blood cells
(c) (i) Success of gene therapy of sickle cell anaemia (From data)
- 5 -
02107020/CAPE/KMS 2021
BIOLOGY
UNIT 1 – PAPER 02
KEY AND MARK SCHEME
1 mark each
3 marks
Question 2 cont’d
Sample Responses:
Delivering the gene to the right place (1). Gene therapies only work
if a normal gene is delivered to a large number of cells in the correct
tissue/crucial new gene reaches correct cells for success of gene
therapy (1). There may be challenges with the vectors which results in
the gene being delivered to the wrong cells (1). If delivered to the
- 6 -
02107020/CAPE/KMS 2021
BIOLOGY
UNIT 1 – PAPER 02
KEY AND MARK SCHEME
wrong cells, it would be inefficient and cause health problems for
patient (1).
Making sure the new gene does not disrupt the function of other genes
(1). Good gene therapy involves the new gene introduced will integrate
into patient’s genome and work for rest of their lives (1). There is
a risk that the gene will insert itself into path of another gene
disrupting its activity (1) this could interfere with important genes
involved in regulating cell division which leads to cancer (tumour
formation)/ leukaemia formation in SCID patients when gene stitched
itself to a gene regulating cell division / insertion of gene into
protooncogene/cancer causing gene (1).
The effects of gene therapy are usually short lived (1). Cells
containing therapeutic DNA should be long lived and stable in order to
have a permanent cure (1). Only treatment of somatic cells is allowed
and somatic cells die and are replaced frequently (e.g lung cells) (1).
Patients therefore need to undergo multiple treatments to achieve
consistent relief (1).
Type of genetic diseases that can be treated (1). Diseases that are
caused by a (single) recessive gene are usually treated because it
does not have to be removed/inactivated/switched off (1) The dominant
allele can mask defective recessive allele when added to the genome
(1) however a disease caused by a dominant allele would have to be
inactivated/turned off which is difficult to do (since many processes
have to be turned off)(1).
(a) (i)
[5 marks XS]
Question 3 cont’d
(c) (i) • A/Ovary wall develops into pericarp / fruit wall of fruit
• B/Ovule/embryo sac develops into seed
Sample Responses:
Total 30 marks